Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function

Cancer Chemother Pharmacol. 2011 Dec;68(6):1639-40; author reply 1641-2. doi: 10.1007/s00280-011-1776-8. Epub 2011 Nov 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Pyridines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Pyridines